Neurocognitive aspects of ketamine and esketamine on subjects with treatment-resistant depression: A comparative, randomized and double-blind study.
Araújo-de-Freitas L, Santos-Lima C, Mendonça-Filho E, Vieira F, França RJAF, Magnavita G, Cardoso TL, Correia-Melo FS, Leal GC, Jesus-Nunes AP, Souza-Marques B, Marback R, Teles M, Echegaray MV, Beanes G, Guerreiro-Costa LNF, Mello RP, Rabanea T, Lucchese AC, Abreu N, Lacerda ALT, Quarantini LC.
Araújo-de-Freitas L, et al. Among authors: cardoso tl.
Psychiatry Res. 2021 Sep;303:114058. doi: 10.1016/j.psychres.2021.114058. Epub 2021 Jun 7.
Psychiatry Res. 2021.
PMID: 34153630
Clinical Trial.